Sumera Irie Ilyas

机构：Mayo Clinic, WinnMed, Mayo Clinic in Arizona · ORCID：0000-0002-2709-3003

发表论文 165 篇 · 总被引 10193 次 · h-index 29

代表论文

• Deep learning analysis of MRI accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis (2025 · Hepatology · 被引 15)
• New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas (2025 · Journal of Hepatology · 被引 14)
• NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts (2025 · Signal Transduction and Targeted Therapy · 被引 13)
• Congestion Enriches Intra-hepatic Macrophages Through Reverse Zonation of CXCL9 in Liver Sinusoidal Endothelial Cells (2025 · Cellular and Molecular Gastroenterology and Hepatology · 被引 12)
• Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab (2024 · JHEP Reports · 被引 11)
• Liver resection with and without vascular resection versus transplantation for de novo perihilar cholangiocarcinoma (2025 · Hepatology · 被引 9)